OneMedNet (NASDAQ:ONMD) Director Buys $20,900.00 in Stock

OneMedNet Corporation (NASDAQ:ONMD) Director Thomas Kosasa bought 55,000 shares of the firm’s stock in a transaction that occurred on Monday, June 16th. The shares were acquired at an average price of $0.38 per share, with a total value of $20,900.00. Following the purchase, the director owned 8,480,824 shares in the company, valued at $3,222,713.12. This trade represents a 0.65% increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink.

Thomas Kosasa also recently made the following trade(s):

• On Wednesday, September 24th, Thomas Kosasa purchased 6,000 shares of OneMedNet stock. The stock was acquired at an average cost of $0.93 per share, for a total transaction of $5,580.00.
• On Friday, August 29th, Thomas Kosasa purchased 581,395 shares of OneMedNet stock. The shares were acquired at an average price of $0.86 per share, with a total value of $499,999.70.

OneMedNet Trading Up 20.8%

ONMD opened at $1.72 on Friday. The business has a 50 day moving average of $1.80 and a 200-day moving average of $1.00. The stock has a market capitalization of $87.47 million, a price-to-earnings ratio of -34.30 and a beta of 1.09. OneMedNet Corporation has a 1-year low of $0.30 and a 1-year high of $4.22.

OneMedNet (NASDAQ:ONMD) last released its earnings results on Friday, November 14th. The company reported ($0.01) EPS for the quarter. The company had revenue of $0.18 million for the quarter.

Analysts Set New Price Targets

ONMD has been the subject of a number of research analyst reports. Wall Street Zen raised shares of OneMedNet to a “hold” rating in a research report on Friday, September 26th. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of OneMedNet in a report on Tuesday, October 14th. One analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the stock has a consensus rating of “Sell”.

Hedge Funds Weigh In On OneMedNet

A number of hedge funds and other institutional investors have recently made changes to their positions in ONMD. Ashton Thomas Private Wealth LLC acquired a new stake in shares of OneMedNet during the 3rd quarter valued at about $25,000. Exencial Wealth Advisors LLC raised its position in OneMedNet by 3.1% in the second quarter. Exencial Wealth Advisors LLC now owns 1,491,862 shares of the company’s stock worth $851,000 after purchasing an additional 45,448 shares in the last quarter. Finally, Correct Capital Wealth Management bought a new position in OneMedNet during the third quarter worth about $4,910,000. 0.95% of the stock is owned by institutional investors.

About OneMedNet

OneMedNet Corporation provides clinical imaging solutions. It offers iRWD, a solution that utilizes AI to securely de-identify, search, and curate imaging data for its partner network consisting of medical and academic research institutions to generate progression in stages of medical research, discovery and diagnostics that span the field of life sciences.